Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Philip Carter, Costi Alifrangis, Biancastella Cereser, Pramodh Chandrasinghe, Lisa Del Bel Belluz, Nina Moderau, Fotini Poyia, Lee S. Schwartzberg, Neha Tabassum, Jinrui Wen, Jonathan Krell, Justin Stebbing
Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17589-17596
Francesco Vasuri, Silvia Fittipaldi, Vanessa De Pace, Laura Gramantieri, Valentina Bertuzzo, Matteo Cescon, Antonio D. Pinna, Michelangelo Fiorentino, Antonia D’Errico, Matteo Ravaioli
Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17895-17905
Laura Devis, Elena Martinez-Garcia, Cristian P. Moiola, Maria Teresa Quiles, Maria Antonia Arbos, Tomita Vasilica Stirbat, Françoise Brochard-Wyart, Ãngel GarcÃa, Lorena Alonso-Alconada, Miguel Abal, Berta Diaz-Feijoo, William Thomas, Sylvie Dufour, Gemma Mancebo, Francesc Alameda, Jaume Reventos, Antonio Gil-Moreno, Eva Colas
Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16648-16664